Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels
| Image |  |
|---|---|
| Description | scholarly article by Gabriela Pavlasova et al published 20 July 2018 in Leukemia |
| Author/s | |
| Publication date | July 20, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |